2017
DOI: 10.1007/s00701-017-3310-1
|View full text |Cite
|
Sign up to set email alerts
|

Pressure reactivity index: journey through the past 20 years

Abstract: Autoregulation after traumatic brain injury can be monitored continuously using simple signal processing of intracranial pressure and arterial blood pressure. The pressure reactivity index (PRx) showed several benefits when it was applied to continuous brain monitoring. Among them, a positive and strong correlation with the outcome and possibility of calculation of 'optimal cerebral perfusion pressure' have been listed. For this methodology, prospective clinical trials are missing-few of them are planned in th… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
52
0

Year Published

2018
2018
2024
2024

Publication Types

Select...
5
4

Relationship

1
8

Authors

Journals

citations
Cited by 59 publications
(53 citation statements)
references
References 20 publications
1
52
0
Order By: Relevance
“…Pressure reactivity index (PRx) is another form of correlation analysis between time domain features and has been particularly well-studied. The PRx is calculated as a moving average correlation coefficient between the 10-s mean of the arterial blood pressure (ABP) signal and the mean ICP signal over a 5-min time window (60). PRx quantifies cerebrovascular reactivity and approximate global cerebral autoregulatory reserve by observing the responses of each signal to slow spontaneous changes.…”
Section: Information: Time Domain Featuresmentioning
confidence: 99%
“…Pressure reactivity index (PRx) is another form of correlation analysis between time domain features and has been particularly well-studied. The PRx is calculated as a moving average correlation coefficient between the 10-s mean of the arterial blood pressure (ABP) signal and the mean ICP signal over a 5-min time window (60). PRx quantifies cerebrovascular reactivity and approximate global cerebral autoregulatory reserve by observing the responses of each signal to slow spontaneous changes.…”
Section: Information: Time Domain Featuresmentioning
confidence: 99%
“…5,8,15 Identifying the "Lethal Dose" of Cerebral Hypoperfusion Currently, the PRx remains the most widely validated surrogate measure of cerebral autoregulation. 9,17 However, the PRx relies on an important assumption that a change in cerebral blood volume would be reflected as a change in ICP. 4 Nonetheless, when the pressure-volume relationship is stable (i.e., the pressure-volume curve is flat, e.g., low ICP), the transmission of volume to pressure is weakened.…”
Section: Cerebral Hypoperfusion After Tbimentioning
confidence: 99%
“…In practice, the status of cerebral autoregulation can be indirectly assessed by measuring the cerebrovascular pressure reactivity. 9 Defined as the moving correlation coefficient between arterial blood pressure (ABP) and intracranial pressure (ICP), the pressure-reactivity index (PRx) has been considered as a de facto surrogate measure of cerebral autoregulation. 17,30,36 Furthermore, in recent years, the PRx has been highlighted for its efficacy in detecting the optimal level of CPP; when plotted against the PRx, a specific point of CPP with the lowest PRx would be identified, which is supposed to be the optimal CPP (CPPopt) with the strongest autoregulatory ability.…”
mentioning
confidence: 99%
“…Functional autoregulation is inferred when an arterial BP (ABP) change is associated with an anticorrelated change in ICP, representing a reduction of flow and hence cerebral blood volume. The correlation coefficient between ABP and ICP is the pressure reactivity index (PRx); positive values indicate a passive response to ABP, associated with loss of autoregulation, while negative values suggest intact autoregulation (for a very concise expert review, refer to [40]). The CPP optimization strategy takes advantage of the ‘U’-shaped relationship between PRx and CPP, in which the minimum PRx represents an optimal CPP (CPPopt).…”
Section: Targeting Fluid Therapymentioning
confidence: 99%